Factors Associated With Glaucoma Surgery in Pediatric Non-Infectious Uveitis

References

• de Boer J, Wulffraat N, Rothova AJ. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879–884. doi:10.1136/bjo.87.7.879.
   PubMed Web of Science ®Google Scholar
• Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P. Prognosis of juvenile rheumatoid arthritis-associated uveitis. Eur J Ophthalmol. 2003;13(7):616–621. doi:10.1177/112067210301300704.
   PubMed Web of Science ®Google Scholar
• Kaur S, Kaushik S, Singh Pandav S. Pediatric uveitic glaucoma. J Curr Glaucoma Pract. 2013;7(3):115–117. doi:10.5005/jp.journals.10008.1147.
   PubMedGoogle Scholar
• Kothari S, Foster CS, Pistilli M, et al. The risk of intraocular pressure elevation in pediatric noninfectious uveitis. Ophthalmology. 2015;122(10):1987–2001. doi:10.1016/j.ophtha.2015.06.041.
   PubMed Web of Science ®Google Scholar
• Muñoz-Negrete FJ, Moreno-Montañés J, Hernández-Martínez P, Rebolleda G. Current approach in the diagnosis and management of uveitic glaucoma. Biomed Res Int. 2015;2015:1–13. doi:10.1155/2015/742792.
   Web of Science ®Google Scholar
• Abu Samra K, Maghsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS. Current treatment modalities of JIA-associated uveitis and its complications: literature review. Ocul Immunol Inflamm. 2016;24(4):431–439. doi:10.3109/09273948.2015.1115878.
   PubMed Web of Science ®Google Scholar
• Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm. 2009;17(4):243–248. doi:10.1080/09273940902913035.
   PubMed Web of Science ®Google Scholar
• Gautam Seth N, Yangzes S, Thattaruthody F, et al. Glaucoma secondary to uveitis in children in a tertiary care referral center. [ published online February 2, 2018]. Ocul Immunol Inflamm. 26:1–9. doi:10.1080/09273948.2017.1411517.
   PubMedGoogle Scholar
• Altman DG . Practical Statistics for Medical Research. 1st ed. New York: Chapman and Hall/CRC; 1990. doi:10.1201/9780429258589.
   Google Scholar
• Krzywinski M, Altman N. Points of significance: power and sample size. Nat Methods. 2013;10(12):1139–1140. doi:10.1038/nmeth.2738.
   Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984;91(10):1247–1252. doi:10.1016/S0161-6420(84.
   PubMed Web of Science ®Google Scholar
• Kotaniemi K, Sihto-Kauppi K. Occurrence and management of ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis: an observational series of 104 patients. Clin Ophthalmol. 2007;1(4):455–459. http://www.ncbi.nlm.nih.gov/pubmed/19668522%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2704536
   PubMedGoogle Scholar
• Leinonen S, Kotaniemi K, Kivelä T, Majander A. Potential effect of tumor necrosis factor inhibitors on trabeculectomy with mitomycin C for patients with juvenile idiopathic arthritis-related uveitic glaucoma a retrospective analysis. JAMA Ophthalmol. 2015;133(11):1323–1328. doi:10.1001/jamaophthalmol.2015.3387.
   PubMed Web of Science ®Google Scholar
• Spaeth GL. European glaucoma society terminology and guidelines for glaucoma, 5th ed. British J Ophthalmol. 2021;105:1–169. doi:10.1136/bjophthalmol-2021-egsguidelines.
   Google Scholar
• Sijssens KM, Rothova A, Berendschot TTJM, de Boer JH. Ocular hypertension and secondary glaucoma in children with uveitis. Ophthalmology. 2006;113(5):853–859.e2. doi:10.1016/j.ophtha.2006.01.043.
   PubMed Web of Science ®Google Scholar
• Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE. Occurrence of and risk factors for ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2017;25(4):503–512. doi:10.3109/09273948.2016.1142573.
   PubMed Web of Science ®Google Scholar
• Ng JSK, Fan DSP, Young AL, et al. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon. Ophthalmology. 2000;107(11):2097–2100. doi:10.1016/S0161-6420(00.
   PubMed Web of Science ®Google Scholar
• Al Hanaineh AT, Hassanein DH, Abdelbaky SH, El Zawahry OM. Steroid-induced ocular hypertension in the pediatric age group. Eur J Ophthalmol. 2018;28(4):372–377. doi:10.1177/1120672118757434.
   PubMed Web of Science ®Google Scholar
• Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500–507. doi:10.1001/archopht.1963.00960050502012.
   PubMed Web of Science ®Google Scholar
• Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11(6):478–483. doi:10.1097/00055735-200012000-00016.
   PubMedGoogle Scholar
• Kaur S, Dhiman I, Kaushik S, Raj S, Pandav SS. Outcome of ocular steroid hypertensive response in children. J Glaucoma. 2016;25(4):343–347. doi:10.1097/IJG.0000000000000209.
   PubMed Web of Science ®Google Scholar
• Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT. Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res (Hoboken). 2014;66(7):1073–1084. doi:10.1002/acr.22214.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/nejmoa1614160.
   PubMed Web of Science ®Google Scholar
• Bitossi A, Bettiol A, Silvestri E, et al. Adalimumab accounts for long-term control of noninfectious uveitis also in the absence of concomitant DMARD treatment: a multicenter retrospective study. Mediators Inflamm. 2019;2019:1–8. doi:10.1155/2019/1623847.
   Web of Science ®Google Scholar
• Utz VM, Bulas S, Lopper S, et al. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis. Pediatr Rheumatol. 2019;17:1. doi:10.1186/s12969-019-0383-9.
   PubMed Web of Science ®Google Scholar
• Wennink RAW, Kalinina Ayuso V, Pameijer EM, Dekkers CC, Bozkir I, de Boer JH. Improved clinical outcomes in patients with juvenile idiopathic arthritis associated uveitis in the last decade. Acta Ophthalmol. 2022;100:781–787. doi:10.1111/aos.15097.
   PubMed Web of Science ®Google Scholar